Dubey, Divyanshu et al "The First Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of an FcRn Inhibitor, Rozanolixizumab, in Patients With Leucine-Rich Gliomainactivated 1 Autoimmune Encephalitis." Neurology 99.23 Supplement 2 (2022): S42-S43. Web. 24 Mar. 2023.

Citation Manager Formats